ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 130 filers reported holding ARRAY BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,325,000 | +27.5% | 265,000 | 0.0% | 0.02% | +30.8% |
Q4 2017 | $3,392,000 | +4.0% | 265,000 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $3,260,000 | +47.0% | 265,000 | 0.0% | 0.01% | +44.4% |
Q2 2017 | $2,218,000 | -6.4% | 265,000 | 0.0% | 0.01% | -10.0% |
Q1 2017 | $2,369,000 | +1.7% | 265,000 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $2,329,000 | +30.2% | 265,000 | 0.0% | 0.01% | +25.0% |
Q3 2016 | $1,789,000 | +89.7% | 265,000 | 0.0% | 0.01% | +100.0% |
Q2 2016 | $943,000 | +20.6% | 265,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $782,000 | -65.0% | 265,000 | -50.0% | 0.00% | -20.0% |
Q4 2015 | $2,236,000 | +85.1% | 530,000 | +100.0% | 0.01% | 0.0% |
Q3 2015 | $1,208,000 | -36.8% | 265,000 | 0.0% | 0.01% | -28.6% |
Q2 2015 | $1,911,000 | -2.2% | 265,000 | 0.0% | 0.01% | -12.5% |
Q1 2015 | $1,953,000 | +55.9% | 265,000 | 0.0% | 0.01% | +60.0% |
Q4 2014 | $1,253,000 | +32.5% | 265,000 | 0.0% | 0.01% | +25.0% |
Q3 2014 | $946,000 | -21.7% | 265,000 | 0.0% | 0.00% | -20.0% |
Q2 2014 | $1,208,000 | – | 265,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |